This Tumor session was recorded live at the 2025 AANS Annual Scientific Meeting.

Adjuvant therapies, such as stereotactic radiosurgery, laser interstitial and targeted systemic treatment, continue to be refined to offer advances in local disease control and overall survival. Participants will learn from debates between leaders in the field and discussions of the future of multidisciplinary skull base tumor treatment.
Speakers: Carlos David, MD, FAANS; Christina Jackson, MD